Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Threshold Pharmaceuticals, Inc.    

THRESHOLD PHARMACEUTICALS, INC.

SummaryChartsNewsRatingsCompany 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector news
Latest news on THRESHOLD PHARMACEUTICALS,
2017THRESHOLD PHARMACEUTICALS : Summary ToggleTakeda and Molecular Templates Announc..
PU
2017Threshold Pharmaceuticals Announces Results of Annual Meeting of Stockholders
GL
2017Threshold Pharmaceuticals Reports Second Quarter Financial Results
GL
2017Threshold Pharmaceuticals Announces First Patient Dosed in Immunotherapy Clin..
GL
2017Threshold Pharmaceuticals Reports First Quarter Financial Results
GL
2017Threshold Pharmaceuticals Reports Fourth Quarter and Full Year 2016 Financial..
GL
2017Threshold Pharmaceuticals and Molecular Templates Agree to Combine
GL
2017Development costs to keep Merck KGaA profit flat this year
RE
2016Threshold Pharmaceuticals and National Cancer Institute to Collaborate on Dru..
GL
2016Threshold Pharmaceuticals Announces Presentation and Webcast at the Stifel He..
GL
2016Threshold Pharmaceuticals Reports Third Quarter Financial Results
GL
2016Threshold Pharmaceuticals Announces Interim Results from Tarloxotinib Program..
GL
2016Threshold Pharmaceuticals Reports Second Quarter Financial Results
GL
2016Threshold Pharmaceuticals Highlights Multiple Presentations at the 2016 ASCO ..
GL
2016Threshold Pharmaceuticals to Present at Jefferies 2016 Healthcare Conference
GL
2016Threshold Pharmaceuticals Reports First Quarter Financial Results
GL
2016Threshold Pharmaceuticals Appoints Stew Kroll as Chief Operating Officer
GL
2016Threshold Pharmaceuticals Provides Corporate Update and Reports Fourth Quarte..
GL
2016Threshold Pharmaceuticals Announces Presentation and Webcast at the Cowen and..
GL
2016THRESHOLD PHARMACEUTICALS : and Merck KGaA, Darmstadt, Germany Agree to Key Term..
MW
2015THRESHOLD PHARMACEUTICALS : Announces Workforce Reduction
MW
2015German Merck Won't Pursue Evofosfamide for Soft Tissue Sarcoma; Theshold Shar..
DJ
2015THRESHOLD PHARMACEUTICALS : Announces Its Two Phase 3 Studies Evaluating Evofosf..
MW
2015THRESHOLD PHARMACEUTICALS : Enters Into Definitive Co-Promotion Agreement for Ev..
MW
2015THRESHOLD PHARMACEUTICALS : Announces Presentation and Webcast at the Stifel 201..
MW
2015THRESHOLD PHARMACEUTICALS : Preclinical Studies Find That Tarloxotinib May Overc..
MW
2015THRESHOLD PHARMACEUTICALS : Announces Preclinical Data on Combination of Evofosf..
MW
2015THRESHOLD PHARMACEUTICALS : Reports Third Quarter 2015 Financial and Operational..
MW
2015THRESHOLD PHARMACEUTICALS : Announces Preclinical Data Presentations on Tarloxot..
MW
2015THRESHOLD PHARMACEUTICALS : Receives Two U.S. Patents for Tarloxotinib Bromide
MW
2015THRESHOLD PHARMACEUTICALS : Appoints Mark Hopkins, J.D., Ph.D., Vice President o..
MW
2015THRESHOLD PHARMACEUTICALS : Announces Presentation and Webcast at the Rodman & R..
MW
2015THRESHOLD PHARMACEUTICALS : Initiates Phase 2 Clinical Trial of Tarloxotinib Bro..
MW
2015THRESHOLD PHARMACEUTICALS : and ATOMIC Initiate First Phase 2 Clinical Trial of ..
MW
2015THRESHOLD PHARMACEUTICALS : Reports Second Quarter 2015 Financial and Operationa..
MW
2015THRESHOLD PHARMACEUTICALS : Announces Presentation and Webcast at the Cantor Fit..
MW
2015THRESHOLD PHARMACEUTICALS : Presents Encouraging Preliminary Phase 2 Data in Mul..
MW
2015THRESHOLD PHARMACEUTICALS : Announces Presentation and Webcast at the Jefferies ..
MW
2015THRESHOLD PHARMACEUTICALS : Announces Clinical Update on Evofosfamide in Relapse..
MW
2015THRESHOLD PHARMACEUTICALS : ' Partner Merck KGaA, Darmstadt, Germany, Receives F..
MW
2015THRESHOLD PHARMACEUTICALS : Announces Presentation and Webcast at the 2015 UBS G..
MW
2015THRESHOLD PHARMACEUTICALS : Reports Preclinical Data Suggesting That TH-4000 May..
MW
2015THRESHOLD PHARMACEUTICALS : to Host Analyst and Investor Day on April 24 in New ..
MW
2015THRESHOLD PHARMACEUTICALS : to Present Data Supporting Planned Phase 2 Trials of..
MW
2015THRESHOLD PHARMACEUTICALS : Reports Fourth Quarter and Year End 2014 Financial a..
MW
2015THRESHOLD PHARMACEUTICALS : Announces Presentation and Webcast at the 2015 Cowen..
MW
2015THRESHOLD PHARMACEUTICALS : Announces Pricing of $30 Million Offering of Common ..
MW
2014THRESHOLD PHARMACEUTICALS : Encouraging Initial Data From Ongoing Phase 1/2 Tria..
MW
2014THRESHOLD PHARMACEUTICALS : Announces Presentations and Webcasts at Upcoming Inv..
MW
2014THRESHOLD PHARMACEUTICALS : Announces Phase 1/2 Interim Data Signaling Activity ..
MW
2014THRESHOLD PHARMACEUTICALS : Receives FDA Fast Track Designation for TH-302 for t..
MW
2014THRESHOLD PHARMACEUTICALS : Announces Presentation and Webcast at the Stifel 201..
MW
2014THRESHOLD PHARMACEUTICALS : Announces New Phase 1/2 Data on TH-302 in Multiple M..
MW
2014THRESHOLD PHARMACEUTICALS : Announces New Phase 1/2 Data on TH-302 in Glioblasto..
MW
2014THRESHOLD PHARMACEUTICALS : Reports Third Quarter 2014 Financial and Operational..
MW
2014THRESHOLD PHARMACEUTICALS : ' Partner Merck KGaA, Darmstadt, Germany, Completes ..
MW
2014THRESHOLD PHARMACEUTICALS : Announces Its Phase 3 Trial of TH-302 in Patients Wi..
MW
2014THRESHOLD PHARMACEUTICALS : Announces Presentation and Webcast at the Rodman & R..
MW
2014THRESHOLD PHARMACEUTICALS : Reports Second Quarter 2014 Financial and Operationa..
MW
2014THRESHOLD PHARMACEUTICALS : Announces Initiation of Dosing With TH-302/Bortezomi..
MW
2014THRESHOLD PHARMACEUTICALS : Initiates 440-Patient, Randomized, Double-Blind, Pla..
MW
2014THRESHOLD PHARMACEUTICALS : Announces Data From Ongoing Phase 1/2 Trial of TH-30..
MW
2014THRESHOLD PHARMACEUTICALS : Announces Data From Ongoing Phase 1/2 Trial of TH-30..
MW
2014THRESHOLD PHARMACEUTICALS : Announces Presentation and Webcast at the Jefferies ..
MW
2014THRESHOLD PHARMACEUTICALS : Announces Webcast of Analyst Event on Sunday, June 1..
PU
2014THRESHOLD PHARMACEUTICALS : Announces Webcast of Analyst Event on Sunday, June 1..
MW
2014THRESHOLD PHARMACEUTICALS : Announces Clinical Data on TH-302 in Glioblastoma an..
MW
2014THRESHOLD PHARMACEUTICALS : Announces Presentation and Webcast at the UBS Global..
MW
2014THRESHOLD PHARMACEUTICALS : CEO Named as Finalist for European Inventor Award
MW
2014THRESHOLD PHARMACEUTICALS : Reports First Quarter 2014 Financial and Operational..
MW
2014THRESHOLD PHARMACEUTICALS : Announces Results of Two New Preclinical Studies Eva..
MW
2014THRESHOLD PHARMACEUTICALS : ' Partner Merck KGaA, Darmstadt, Germany Initiates P..
MW
2014Threshold Pharmaceuticals Reports Fourth Quarter and Year End 2013 Financial ..
MW
2014Threshold Pharmaceuticals Announces Presentations and Webcasts at Three Upcom..
MW
2013Threshold Pharmaceuticals Announces Target Enrollment of 620 Patients Achieve..
MW
1  2Next